HELIX

About Lant Medical

Lant Medical is a private, pre-revenue biotech focused on a significant global health challenge: Helicobacter pylori infection. The company's lead program, HELIX, is a novel therapeutic designed to treat the root cause and symptoms of H. pylori, potentially as a monotherapy or adjunct to existing antibiotics. Targeting a market of over 4 billion infected individuals, Lant aims to commercialize HELIX first as an over-the-counter product, followed by a clinically tested prescription therapy. The company appears to be in a pre-clinical or early development stage, leveraging a platform that may involve novel drug delivery mechanisms for gastrointestinal pathogens.

Therapeutic Areas

Other Helicobacter pylori infection Drugs